C-section 'link' to child obesity
Babies who are delivered through Caesarean section are twice as likely to become obese than those born traditionally, US research suggests. (Source: BBC News | Health | UK Edition)
Aegerion adds chief medical officer, will replace director
Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) has announced the appointment of a new Chief Medical Officer and a new board member. The Cambridge, Mass.-based biotechnology company also disclosed in a regulatory filing that one of its board directors plans to resign.
Aegerion has tapped former Bristol-Myers Squibb (NYSE: BMY) executive, Dr. Mark Sumeray, to take on the role of Chief Medical Officer. Dr. Sumeray has worked on popular approved cardiovascular drugs including Plavix, apixaban, Avapro/Avalide, and Angiomax and served most recently as Vice President Cardiovascular/Metabolics U... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
